|
CA2503087A1
|
|
Intravenous formulations of pyridoxal 5'-phosphate and method of preparation
|
|
CA2520422A1
|
|
Compositions for treating angina
|
|
WO2004084895A2
|
|
Modulation of cell death
|
|
US6489345B1
|
|
Treatment of diabetes and related pathologies
|
|
EP1493443A1
|
|
Use of pyridoxal phosphate for the treatment of diabetes and related complications
|
|
EP1897547A1
|
|
Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
|
|
EP1832291A2
|
|
use of pyridoxal phosphate for the treatment of diabetes and related complications
|
|
WO0053606A1
|
|
Pyridoxal analogues for vitamin b-6 disorders
|
|
US6043259A
|
|
Treatment of cardiovascular and related pathologies
|
|
US6051587A
|
|
Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
|
